AngioDynamics reported an 6.9% increase in Net Sales to $80.9 million for Q1 FY27, driven by double-digit Med Tech growth. The company also announced Eric Honroth as the new CEO to succeed Jim Clemmer.
AngioDynamics reported an 6.9% increase in Net Sales to $80.9 million for Q1 FY27, driven by double-digit Med Tech growth. The company also announced Eric Honroth as the new CEO to succeed Jim Clemmer.